---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-018553"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2025-07-10T23:59:59+00:00"
generated_at: "2026-05-18T08:47:18.900900+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics raises $4.6M via warrant exercise at $0.70/share

## Summary
- Gross proceeds ~$4.6M from immediate exercise of 6,595,000 warrants at $0.70/share.
- New Series H warrants issued for up to 6,595,000 shares at $0.70, exercisable after 6 months.
- 7 warrant holders participated; closing expected July 10, 2025.
- Net proceeds for clinical programs and working capital.
- Ladenburg Thalmann acts as placement agent with 8% fee.

## SEC filing metadata
- accession: 0001641172-25-018553
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2025-07-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000164117225018553/0001641172-25-018553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000164117225018553/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-018553
- JSON: https://secwatch.observer/filing/0001641172-25-018553.json
- Plain text: https://secwatch.observer/filing/0001641172-25-018553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.